News

TipRanks on MSN3d
GSK’s Promising Study on Belimumab for Lung Disease: What Investors Need to Know
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
TipRanks on MSN5d
GSK’s Promising Study on Belimumab for Systemic Sclerosis Lung Disease
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
The American Journal of Managed Care20h
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic ...
CURE3d
FDA Approves Hernexeos for Non-Squamous Non-Small Cell Lung Cancer
The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.
MedPage Today3d
Novel Drug for HER2-Mutant Lung Cancer Wins FDA Approval
The FDA on Friday granted accelerated approval to zongertinib (Hernexeos) for non-squamous non-small cell lung cancer (NSCLC) ...
Healio4d
ILD diagnosis raises risk for lung cancer
Individuals with vs. without interstitial lung disease faced an elevated risk for lung cancer and histological subtypes of lung cancer in adjusted and sibling-controlled analyses, according to results ...